Cargando…

Hydroa vacciniforme-like lymphoproliferative disorder (HV-LPD) is an Epstein-Barr virus (EBV) associated disease()()

Detalles Bibliográficos
Autores principales:	Ordoñez-Parra, Juliana, Mejía Cortes, Maddy, Tamayo-Buendía, Maria Margarita, Infante Gómez, Ana María
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Dermatologia 2021
Materias:	Case Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178562/ https://www.ncbi.nlm.nih.gov/pubmed/33849755 http://dx.doi.org/10.1016/j.abd.2020.06.023

Ejemplares similares

Hydroa Vacciniforme and Hydroa Vacciniforme-Like Lymphoproliferative Disorder: A Spectrum of Disease Phenotypes Associated with Ultraviolet Irradiation and Chronic Epstein–Barr Virus Infection
por: Chen, Chien-Chin, et al.
Publicado: (2020)

Hydroa vacciniforme-like lymphoproliferative disorder in Korea
por: Han, Byeol, et al.
Publicado: (2020)

Extensive hydroa vacciniforme
por: de Almeida, Hiram Larangeira, et al.
Publicado: (2013)

Hydroa Vacciniforme-Like Lymphoproliferative Disorder in Korea: Prognostic Implication of Clinical Signs and Whole Blood Epstein-Barr Virus DNA
por: Oh, Se Jin, et al.
Publicado: (2021)

Hydroa Vacciniforme-Like Eruption Associated with Epstein-Barr Virus Infection in an Older Adult
por: Jung, Soo-Eun, et al.
Publicado: (2015)

Hydroa Vacciniforme-Like Lymphoproliferative Disorder in an Adult Patient With Chronic Lymphocytic Leukemia
por: Chee, Ashlyn, et al.
Publicado: (2020)

A Case of Hydroa Vacciniforme-Like Lymphoproliferative Disorder Presenting As Orogenital Ulcerations
por: Li, Yingyi, et al.
Publicado: (2022)

Case report: Cellular therapy for hydroa vacciniforme-like lymphoproliferative disorder in pediatric common variable immunodeficiency with chronic active Epstein-Barr virus infection
por: Grześk, Elżbieta, et al.
Publicado: (2022)

Chronic active Epstein–Barr virus and hydroa vacciniforme‐like lymphoproliferative disorder in a pediatric patient complicated by fatal ruptured cerebral artery aneurysm
por: Yi, Troy, et al.
Publicado: (2023)

The face of CD4(+) Hydroa Vacciniforme-Like Lymphoproliferative Diseases: The Shadow of Systemic T-Cell Lymphoma
por: Kim, Young Jae, et al.
Publicado: (2019)

Hydroa Vacciniforme-Like Cutaneous T-cell Lymphoma
por: Shi, Jian-Qiang, et al.
Publicado: (2014)

Hydroa vacciniforme as a differential diagnosis of atopic dermatitis
por: Brom, Lucas, et al.
Publicado: (2015)

Hydroa vacciniforme‐like lymphoproliferative disorder: A clinicopathological, immunohistochemical, and prognostic study of 24 cases in China
por: Wang, Xinhua, et al.
Publicado: (2021)

Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases
por: Guo, Na, et al.
Publicado: (2019)

Clinical and Pathological Features of Hydroa Vacciniforme-Like Lymphoproliferative Disorder Along with Risk Factors Indicating Poor Prognosis
por: Chang, Li, et al.
Publicado: (2023)

Hydroa Vacciniforme-Like Lymphoma with Systemic Symptoms: Two Case Reports
por: Wang, Litao, et al.
Publicado: (2019)

Hydroa Vacciniforme-like Lymphoproliferative Disorder Treated with Intravenous Immunoglobulin: Long-term Remission Without Haematopoietic Stem Cell Transplantation or Chemotherapy
por: RUAN, YePing, et al.
Publicado: (2020)

Hydroa vacciniforme-like lymphoma of an adult: a case report with review of the literature
por: Wang, Mi, et al.
Publicado: (2013)

Adult-onset Hydroa Vacciniforme: A Rare Occurrence or a Lymphoma Premonition?
por: Sangwan, Ankita, et al.
Publicado: (2017)

Refractory Hydroa Vacciniforme-like Lymphoma: Biological Insights from Morphoproteomic Analysis
por: Goswamy, Rohit, et al.
Publicado: (2022)

Hydroa Vacciniforme-like Lymphoproliferative disorder in an adult invades the liver and bone marrow with clear pathological evidence: a case report and literature review
por: Wang, Xiankun, et al.
Publicado: (2021)

Atypical hydroa vacciniforme mimicking dermatomyositis: A case report in a Lebanese girl
por: Hijazi, Maya, et al.
Publicado: (2015)

Hydroa vacciniforme-like cutaneous T-cell lymphoma in a child: A case report
por: Li, Jingyi, et al.
Publicado: (2018)

Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders
por: Dugan, James P., et al.
Publicado: (2019)

Adult-onset hydroa vacciniforme-like lymphoma in a long-term resident of the United States
por: Yu, Kenneth K., et al.
Publicado: (2018)

Coexpression of natural killer cell antigens by T-cell large granular lymphocytes in hydroa vacciniforme lymphoproliferative disorder and the involvement of Vδ1 + epithelial-type γδT cells
por: Hirai, Yoji, et al.
Publicado: (2023)

Marked Increase of Circulating Double-Negative γδ T Cells in a Patient With Hydroa Vacciniforme-Like Lymphoma
por: Shin, Sang-Yong, et al.
Publicado: (2016)

Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle?
por: Tatfi, Moussab, et al.
Publicado: (2019)

Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man
Publicado: (1991)

Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)-induced lymphoproliferative disease and lytic viral replication
por: Bilger, Andrea, et al.
Publicado: (2017)

Somatic changes in B-lymphoproliferative disorders (B-LPD) detected by DNA-fingerprinting.
por: de Jong, D., et al.
Publicado: (1988)

Autoimmune Lymphoproliferative Syndrome and Epstein-Barr Virus-Associated Lymphoma: An Adjunctive Diagnostic Role for Monitoring EBV Viremia?
por: Pace, Romina, et al.
Publicado: (2013)

Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes
por: Mika, Thomas, et al.
Publicado: (2019)

Timing LPD
Publicado: (1984)

641. Limited Utility of Epstein-Barr Virus (EBV) Surveillance for Predicting Post-Transplant Lymphoproliferative Disorder in EBV Seropositive Adult Lung Transplant Recipients
por: Heldman, Madeleine R, et al.
Publicado: (2023)

Epstein-Barr Virus (EBV)-Associated Haemophagocytic Syndrome
por: Torti, Lorenza, et al.
Publicado: (2012)

Counteracting survival functions of EBNA3C in Epstein-Barr virus (EBV)-driven lymphoproliferative diseases by combination of SAHA and bortezomib
por: Hui, Kwai Fung, et al.
Publicado: (2018)

X‐linked lymphoproliferative syndrome associated with Epstein–Barr virus encephalitis and lymphoproliferative disorder
por: Mukai, Takeo, et al.
Publicado: (2023)

Characterization of Epstein-Barr virus (EBV)-infected cells in EBV-associated hemophagocytic lymphohistiocytosis in two patients with X-linked lymphoproliferative syndrome type 1 and type 2
por: Yang, Xi, et al.
Publicado: (2012)

Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease
por: Vickers, Mark A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_min82fmhs281er9aghmi912efl